ENvue Medical

$NanoVibronix(NAOV)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-023542  Act: 34  Size: 6 MB 网页链接

$NanoVibronix(NAOV)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001493152-25-026247  Act: 34  Size: 246 KB 网页链接

$ENvue Medical(NAOV)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-25-029018  Act: 34  Size: 1 MB 网页链接

$ENvue Medical(NAOV)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-25-028390  Size: 3 KB 网页链接

$ENvue Medical(NAOV)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-25-028388  Size: 3 KB 网页链接

$ENvue Medical(NAOV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003831  Act: 33  Size: 2 KB 网页链接

$NanoVibronix(NAOV)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-25-021353  Act: 34  Size: 4 MB 网页链接

$NanoVibronix(NAOV)$ 8-K Current report, item 7.01 Accession Number: 0001493152-25-024167  Act: 34  Size: 245 KB 网页链接

$ENvue Medical(NAOV)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-25-028374  Act: 33  Size: 202 KB 网页链接

$ENvue Medical(NAOV)$ 8-K Current report, items 5.03, 7.01, and 9.01 Accession Number: 0001493152-25-027380  Act: 34  Size: 247 KB 网页链接

$NanoVibronix(NAOV)$ ARS Annual Report to Security Holders Accession Number: 0001493152-25-021357  Act: 34  Size: 2 MB 网页链接

$NanoVibronix(NAOV)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-25-026987  Act: 33  Size: 484 KB 网页链接